Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 776.7 | 837.7 | 911.5 | | |
| Revenue growth | -7.3% | -8.1% | | | |
| Cost of goods sold | 700.4 | 761.1 | 838.9 | | |
| Gross profit | 76.3 | 76.6 | 72.6 | | |
| Gross margin | 9.8% | 9.1% | 8.0% | | |
| Selling, general and administrative | 81.3 | 84.8 | 105.1 | | |
| Research and development | 30.2 | 34.8 | 37.0 | | |
| EBIT | -33.7 | -40.0 | -60.4 | | |
| EBIT margin | -4.3% | -4.8% | -6.6% | | |
| Pre-tax income | -109.9 | -87.8 | -11.3 | | |
| Income taxes | 26.1 | 2.6 | 44.0 | | |
| Net income | -136.7 | -91.8 | -52.9 | | |
| Net margin | -17.6% | -11.0% | -5.8% | | |
| |
| Diluted EPS | ($3.28) | ($2.21) | ($1.27) | | |
| Shares outstanding (diluted) | 41.7 | 41.5 | 41.5 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|